Peregrine Pharmaceuticals, Inc. (PPHM) Appoints New Head of Medical Oncology, Advances Randomized Phase II Trials
Peregrine Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, announced the appointment of Kerstin B. Menander, M.D., Ph.D. as the head…